Trials / Unknown
UnknownNCT04245566
Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
Prostatic Artery Embolization vs. Pharmacotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: a Multicenter Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 425 (estimated)
- Sponsor
- Dominik Abt · Academic / Other
- Sex
- Male
- Age
- 45 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study compares safety and efficacy of prostatic artery embolization and pharmacotherapy in the treatment of lower urinary tract symptoms associated wit benign prostatic hyperplasia.
Conditions
- Benign Prostatic Hyperplasia
- Pharmacotherapy
- Prostatic Artery Embolization
- Minimally Invasive Treatment
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Prostatic Artery Embolization (PAE) | Prostatic artery embolization will be performed under local anesthesia according to well established and standardized techniques. |
| DRUG | Pharmacotherapy | Pharmacotherapy will be performed using α1-blockers and 5α-reductase inhibitors in accordance with the EAU recommendations |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-12-01
- Completion
- 2025-12-01
- First posted
- 2020-01-29
- Last updated
- 2021-01-26
Source: ClinicalTrials.gov record NCT04245566. Inclusion in this directory is not an endorsement.